Enrolling By Invitation PHASE4 INTERVENTIONAL 1-arm NCT06574425

Long-term, High Blood Flow Hemoadsorption Therapy in Patients Undergoing Maintenance Hemodialysis

A Multicenter, Prospective, Cohort Study on the Safety and Efficacy of Long-term, High Blood Flow Hemoadsorption Therapy in Patients Undergoing Maintenance Hemodialysis

Sponsor: Dongliang Zhang, MD

Conditions Chronic Kidney Diseases Hemodialysis

Interventions long-term, high blood flow hemoadsorption therapy

Updated 2 times since 2024 Last updated: Dec 14, 2024 Started: Aug 28, 2024 Primary completion: May 31, 2025 Completion: Aug 31, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Chronic Kidney Diseases and Hemodialysis and is currently ongoing. Dongliang Zhang, MD leads this study, which shows 2 recorded versions since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

2 versions recorded

Jan 2025 — Present [monthly]

Enrolling By Invitation PHASE4

Status: Recruiting → Enrolling By Invitation · Phase: NA → PHASE4
Sep 2024 — Jan 2025 [monthly]

Recruiting NA

First recorded

Aug 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Dongliang Zhang, MD

Data source: Capital Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China